Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ENROLLING_BY_INVITATION
PHASE3
2100 participants
INTERVENTIONAL
2022-06-18
2024-12-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Vaccine Prevention of Rabies Adopts 4-shot Immunization Method
NCT05549908
Observation on the Immune Persistence of People Aged 10-60 Years Old Immunized With Five Doses of Rabies Vaccine
NCT05547815
A Phase 3 Clinical Trial for a Rabies Vaccine (Vero Cell) for Human Use in Healthy Chinese Subjects
NCT02491541
A Clinical Trial of Freeze-dried Human Rabies Vaccine (Vero Cells)
NCT04852068
Clinical Trial of Freeze-dried Human Rabies Vaccine (Without Serum Vero Cells)
NCT05969626
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
* To evaluate the consistency of immunogenicity between batches of freeze-dried human rabies vaccine (Vero cell) inoculated according to five dose immunization procedures (0, 3, 7, 14, 28 days).
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
4 doses
Inoculate rabies vaccine according to 1-1-1-1 immunization procedure
immunization procedures
The subjects were vaccinated with rabies vaccine according to different immunization procedures
5 doses
Inoculate rabies vaccine according to 1-1-1-1-1 immunization procedure
immunization procedures
The subjects were vaccinated with rabies vaccine according to different immunization procedures
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
immunization procedures
The subjects were vaccinated with rabies vaccine according to different immunization procedures
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Body temperature on the day of enrollment\<37.3℃ (axillary temperature)
Exclusion Criteria
* People with congenital or acquired immunodeficiency or other autoimmune diseases；
* Female urine pregnancy test is positive, or during pregnancy and lactation, or she has a birth plan during the study period;
10 Years
60 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Changchun Zhuoyi Biological Co., Ltd
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Li Miao
Role: STUDY_DIRECTOR
Changchun Zhuoyi Biological Co., Ltd
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Changchun Zhuoyi Biological Co., Ltd
Changchun, Jilin, China
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
ZY202106001
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.